Vonoprazan is associated with a phenotype-specific increase in cholangitis reporting in immune checkpoint inhibitor-treated patients: a VigiBase pharmacovigilance study

Journal of Gastroenterology · Published 2026-06-26 · DOI 10.1007/s00535-026-02469-3

Free full text

Authors (6)

Kazuyuki Mizuno, Basile Chretien, Kazuki Nishida, Takanori Ito, Hiroki Kawashima, Yuichi Ando

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Mizuno, K., Chretien, B., Nishida, K., et al. (2026). Vonoprazan is associated with a phenotype-specific increase in cholangitis reporting in immune checkpoint inhibitor-treated patients: a VigiBase pharmacovigilance study. Journal of Gastroenterology. https://doi.org/10.1007/s00535-026-02469-3

Related articles

• Clinical characteristics of acute pancreatitis in patients with inflammatory bowel disease: a nationwide survey in Japan · Journal of Gastroenterology · 2026 · Same journal
• Conversion surgery for unresectable pancreatic ductal adenocarcinoma with liver metastasis at initial diagnosis: a nationwide multicenter study · Journal of Gastroenterology · 2026 · Same journal
• Diagnostic performance of magnifying endoscopy with third-generation narrow-band imaging for early gastric cancer: post hoc analysis of a randomized trial (3G detection trial) · Journal of Gastroenterology · 2026 · Same journal
• Comment on “Intestinal obstruction impairs the antitumor function of hepatic natural killer cells against colorectal cancer” · Journal of Gastroenterology · 2026 · Same journal
• Clinical applications of gut microbiome for non-invasive diagnosis of colorectal neoplasia · Journal of Gastroenterology · 2026 · Same journal
• Dependence-related screening positivity among regular stimulant-laxative users with chronic constipation: a multicenter prospective observational study · Journal of Gastroenterology · 2026 · Same journal
• A modified Delphi consensus on fusion (laparoscopic and robotic) approaches to colorectal surgery in Asia–Pacific · Journal of Gastroenterology · 2026 · Same journal
• HOXC9 enhances cholesterol metabolism and malignancy in pancreatic ductal adenocarcinoma through ITGA10/FAK/PI3K/CREB-dependent HMGCR activation · Journal of Gastroenterology · 2026 · Same journal
• Evidence-based clinical practice guidelines for metabolic dysfunction-associated steatotic liver disease (MASLD) 2026 · Journal of Gastroenterology · 2026 · Same journal
• Rethinking HLA-based predictors of infliximab persistence and immunogenicity in Japanese IBD: beyond DQB1*03:01 and DQA1*05:05 · Journal of Gastroenterology · 2026 · Same journal